Den anden undersøgelse omfattede 118 voksne, som tidligere havde fået en anden proteasehæmmer.
The second study included 118 adults who had taken another protease inhibitor in the past, comparing Kaletra with a protease inhibitor chosen by the study investigator on a patient-by-patient basis.